Methods
To create a data set for the hysterectomy patient registry, a qualitative Delphi method was employed using multiple rounds of data collection conducted between March and June of 2021. This stage included information needs assessment, data elements identification, registry software development, and field-testing the system.
After reviewing the relevant research topics and existing similar national and international registration systems, also interviews with experts in the field of gynecology the content analysis method was employed to prepare core data elements. Content analysis is an effective approach to determine the presence of specific words, themes, or concepts in qualitative data such as literature [ 21 ].
During this phase of study, the comprehensive search was conducted to gather relevant information across various database and search engine including PubMed, Embase, Scopus, Cochrane, and Google Scholar. In addition, we searched Iranian databases including Irandoc, SID, and Magiran to retrieve articles in the Persian language. “Dataset”, “MDS”, “minimum data set”, “registry”, “hysterectomy”, “patient registry” and “Database” and their Subject Headings (MeSH) were the keywords used in conducting the search strategy. Except for hysterectomy forms, only publications in Persian and English languages published between May 2000 and May 2021 were included. Letters to editors and reports retrieved from websites were excluded. All related data elements of the final selected full texts were recorded for use in the Delphi questionnaire. The expert panel method was then employed used to select the data set. This method is based on the consensus and alignment of experts on the study subject and question. This method has been used in a large number of studies to determine the minimum data set that requires agreement on important data elements [ 22 , 23 ].
In this study Expert panel members included two Gynecological oncologists, one assistant professor of laparoscopic surgery, one urogynecologist, one Infertility Fellowship, and two specialists in Health Information Management. In the next phase, we developed a semi-structured electronic questionnaire containing a comprehensive list of data elements to identify MDS. Also expert opinions were collected and applied in the final checklist [ 24 ]. Additionally, the expert panel specified which data were mandatory and which were optional. After determining the data set for the registry, a data dictionary was prepared for design of the registration software. Subsequently inclusion and exclusion criteria were defined. Exclusion criteria were age over 65 years, emergency hysterectomy, and malignant hysterectomy.
In the next step, the hysterectomy patient registration software was designed to collect data from health centers using the model sampling method. The prototype model was employed a software development model in which a prototype is iteratively constructed and tested until a satisfactory version is achieved [ 16 , 23 ].
The hysterectomy registration software is a web-based application developed using Visual Studio2019. The main framework is ASP.NET MVC, with C# as the development language. The data is stored in a SQL Server database. The Hysterectomy registration software was shared with three members of the project team at http://irhyst.ir for testing and consulting. Then to finalize and adress problems from the initial version of the software, several meetings were held conducted with the software design team. In the next step, the identified mandatory data set in the software, and its completion was required to answer the questions on the next pages. Additionally, the registry dashboard dynamically provided important reports as requested by Physicians, allowing them to select the desired time period.
After the software preparation, the registration program was run as a pilot. Al-Zahra Hospital, a prominent referral teaching hospital in northwestern Iran (located in Tabriz city), was chosen for this initial implementation. During the pilot implementation of the registry program for three weeks, several changes in values and ambiguous questions were made. This modifications included refining values, clarifying ambiguous questions, adding or removing data elements, adjusting titles, and fine-tuning the values associated with specific elements.
After the pilot step, in the second phase, we will initiate implementing a hysterectomy patient registry in health centers of Tabriz City from August 2023.
Results
As part of system requirements, the team of experts prioritized the need to record and report on diverse hysterectomy procedures, along with their respective percentage distributions. Additionally, the system should capture patient age averages, primary reasons for hysterectomy, and common pathology findings. The system design should allow for the creation of printed reports and the retrieval of system outputs, as requested by the experts. All these essential performance metrics have been seamlessly integrated into the system dashboard.
In the information sources review step, a total of 101 data elements were identified across 22 subclasses and 11 main classes. Based on the expert panel opinion, we removed 12 data elements and added 2 new data elements (for evaluating interventions). Unnecessary values for certain elements, such as Urinary incontinence, Surgery turn, Surgeon’s medical system number, and Surgeon Assistant System Number, have been removed. Some data elements were added to the data classes such as suspension and incisions. Here are the adjustments made to enhance data quality:
Bleeding rate and uterine weight have been changed from mandatory to optional due to the unavailability of information. To maintain data quality, we have set minimum and maximum data limits for quantitative variables, preventing the entry of outliers.
Bleeding rate and uterine weight have been changed from mandatory to optional due to the unavailability of information.
To maintain data quality, we have set minimum and maximum data limits for quantitative variables, preventing the entry of outliers.
The final data set for the hysterectomy patient registry comprises 11 main groups, 27 subclasses, and 91 data elements (as detailed in Table 1 ). The 26 administrative data elements, were classified into 5 categories: Demographic data, Socioeconomic, address, Patient ADT, and registrant relate data (Table 2 ).
Table 1 Data set of hysterectomy patient registry Main groups The number of main classes The number of subclasses The number of the data elements Administrative data 3 6 26 Patient History 1 3 13 Operation data 2 7 18 Additional interventions 2 5 16 Perioperative complications 1 3 9 Follow up data 2 3 9 Total 11 27 91
Data set of hysterectomy patient registry
Table 2 Administration data Main class Subclass Mandatory/ Optional data Data elements The Number of data elements patient Profile Demographic data M M National identity number, Patient name, Patient surname, Date of birth, marital status 5 Socio-economic O M Educational degree, Job title (Employment status), Type of residence (urban, suburban, rural) 3 address M Mobile phone number, Telephone number, address details 3 Hospital profile specifications Patient ADT M M O M M M 0 Healthcare center name, Patient HIS- ID Date of admission, Date of discharge or death or transfer of the patient to another center, Date of the patient fallow up inpatient day bed (normal ward + ICU), Number of normal beds, Number of ICU beds, The patient’s condition at the time of discharge (partial recovery/ discharge with personal consent/referral to another centers /Death) If the patient dies in the hospital: the cause of death must be completed 10 Data registrar profile Data registrar specifications M M Registrar ID, Date of data registration, Registrar name, Registrar surname, Role 5
Administration data
M
M
O
M
Educational degree, Job title (Employment status),
Type of residence (urban, suburban, rural)
specifications
Patient ADT
M
M
O
M
M
M
0
Healthcare center name, Patient HIS- ID
Date of admission, Date of discharge or death or transfer of the patient to another center,
Date of the patient fallow up
inpatient day bed (normal ward + ICU), Number of normal beds, Number of ICU beds,
The patient’s condition at the time of discharge (partial recovery/ discharge with personal consent/referral to another centers /Death)
If the patient dies in the hospital: the cause of death must be completed
Data registrar
profile
Data registrar
specifications
M
M
Patient history such as previous pregnancy and previous delivery, method history of surgery, and comorbidities such as hypertension were classified under the patient history subgroup (as detailed in Table 3 ).
Table 3 Patient history Main class Subclass Mandatory/ Optional data Data elements The Number of data elements Patient History General health state M M Smoking (Number per day) alcohol consumption (Consumption per week) height, Weight BMI (BMI ≥ 18 = slimming / BMI ≥ 25 = normal /BMI ≥ 30 = overweight / BMI ≥ 35 = obese/ BMI ≥ 40 = morbid obesity) Body mass status 6 Obstetric and gynecological history M M M M Menopausal status (Before menopause / menopause) Previous pregnancy history Number of deliveries Previous delivery method (NVD / Cesarean / Both) 4 Comorbidities O M M Taking Anti-coagulant drugs, Previous surgical history (laparotomy /laparoscopy laparotomy and laparoscopy) Disease history (Arterial hypertension / insulin-dependent diabetes/ Type 2 diabetes /Previous or family history of deep vein thrombosis (DVT) / heart disease/ Other 3
Patient history
M
M
Smoking (Number per day)
alcohol consumption (Consumption per week)
height, Weight
BMI (BMI ≥ 18 = slimming / BMI ≥ 25 = normal /BMI ≥ 30 = overweight / BMI ≥ 35 = obese/ BMI ≥ 40 = morbid obesity)
Body mass status
M
M
M
M
Menopausal status (Before menopause / menopause)
Previous pregnancy history
Number of deliveries
Previous delivery method (NVD / Cesarean / Both)
O
M
M
Taking Anti-coagulant drugs,
Previous surgical history (laparotomy /laparoscopy
laparotomy and laparoscopy)
Disease history (Arterial hypertension / insulin-dependent diabetes/ Type 2 diabetes /Previous or family history of deep vein thrombosis (DVT) / heart disease/ Other
In Table 4 Operation data were divided into 2 main groups: general and specialized Surgical information. Surgical approach, medical treatment during surgery, Anesthesia data, operation indications, method, and operation findings were placed in the subgroup of specialized surgical information.
Table 4 Operation data Main class Subclass Mandatory/ Optional data Data elements The Number of data elements General information about surgery General operation data M M O M Date of surgery, Surgery time: Duration of operation from the first incision to the last suture (Hours& minutes) Uterine weight (g) without ovaries 4 Profile of surgeons M O O Surgeon’s name Name of the Assistant Surgeon Experience of hysterectomy surgery (less than 10, between 10 and 30, more than 30 3 Anesthesia data O M ASA performance level: (ASA-1 a , ASA-2 b , ASA-3 c , ASA-4 d ,) anesthesia method (General, Spinal, Epidural) 2 Specialized surgical information Indication method type Preoperative intervention surgical approach M M M M M M M M O O Indication: uterine fibroids, Dysfunctional /abnormal uterine bleeding, endometriosis, adenomyosis, Leiomyomas, uterine prolapse, atypical endometrial hyperplasia, infectious disease of the internal genitals, Chronic pelvic pain, Cytological suspicion of endometrial and glandular precancers, Family disp. for Gyn cancer, Surgical method: (abdominal, vaginal, laparoscopic) Type: (total, subtotal, radical) Surgical Approach: abdominal (Total abdominal hysterectomy, Supracervical hysterectomy, radical hysterectomy) Vaginal: (Total, laparoscopically assisted vaginal hysterectomy [ LAVH], Radical vaginal hysterectomy, Other and unspecified vaginal hysterectomy) Laparoscopic: (Total laparoscopic hysterectomy [TLH], vaginal top sutured laparoscopically), Laparoscopic supracervical hysterectomy [LSH], Vaginal-Assisted Laparoscopic Radical Hysterectomy (LRVH)) Vaginal misoprostol / intracervical normal saline infiltration Abdominal incision approach: Paramedian incision, Pfannenstiel incision, Cherney incision, Vertical incision, maylard incision Colpotomy: (Use of unipolar current/ Use of bipolar current/Use of ultrasound/Use of cold scissors - knife) uterus removal management: Removal of uterus in toto(fully), Sharing/ coring with knife/scissors, Use of power morcellator, 9 a without systemic disease, b Mild systemic disease – c without functional impairment. d Severe systemic disease – dysfunction
Operation data
General
operation
data
M
M
O
M
Date of surgery, Surgery time: Duration of operation from the first incision to the last suture (Hours& minutes)
Uterine weight (g) without ovaries
M
O
O
Surgeon’s name
Name of the Assistant Surgeon
Experience of hysterectomy surgery (less than 10, between 10 and 30, more than 30
O
M
ASA performance level: (ASA-1 a , ASA-2 b , ASA-3 c , ASA-4 d ,)
anesthesia method (General, Spinal, Epidural)
Indication
method type
Preoperative intervention
surgical approach
M
M
M
M
M
M
M
M
O
O
Indication: uterine fibroids, Dysfunctional /abnormal uterine bleeding, endometriosis, adenomyosis, Leiomyomas, uterine prolapse, atypical endometrial hyperplasia, infectious disease of the internal genitals, Chronic pelvic pain, Cytological suspicion of endometrial and glandular precancers, Family disp. for Gyn cancer,
Surgical method: (abdominal, vaginal, laparoscopic)
Type: (total, subtotal, radical)
Surgical Approach: abdominal (Total abdominal hysterectomy, Supracervical hysterectomy, radical hysterectomy)
Vaginal: (Total, laparoscopically assisted vaginal hysterectomy [ LAVH], Radical vaginal hysterectomy, Other and unspecified vaginal hysterectomy)
Laparoscopic: (Total laparoscopic hysterectomy [TLH], vaginal top sutured laparoscopically), Laparoscopic supracervical hysterectomy [LSH], Vaginal-Assisted Laparoscopic Radical Hysterectomy (LRVH))
Vaginal misoprostol / intracervical normal saline infiltration
Abdominal incision approach:
Paramedian incision, Pfannenstiel incision, Cherney incision, Vertical incision, maylard incision
Colpotomy: (Use of unipolar current/ Use of bipolar current/Use of ultrasound/Use of cold scissors - knife)
uterus removal management: Removal of uterus in toto(fully), Sharing/ coring with knife/scissors, Use of power morcellator,
a without systemic disease, b Mild systemic disease – c without functional impairment. d Severe systemic disease – dysfunction
In addition, a subgroup of technical and surgery approaches has been set up to include Abdominal incision approach, Surgical technique or Suspension as well as other interventions such as Salpingectomy and associated treatments like Enterocele correction. Prophylaxis was also classified as a medical condition during surgery under the category of treatment(Table 5 ).
Table 5 Additional interventions & accompanying treatment Main class Subclass Mandatory/ Optional data Data elements The Number of data elements Peri-operative intervention Additional interventions Additional interventions M M M M Salpingectomy: By tomi, By laparoscopy, In case of vaginal surgery: Right TUL1/ Left TUL2 Salpingo-oophorectomy: By tomi or vaginal/ unilat, By tomi or vaginal bilat, By laparoscopy unilat, By laparoscopy bilat Prolapse surgery: Front wall plastic, back wall plastic Colpoperineoplasty 5 Accompanying treatment measures accompanying actions M M M Adherence solution, larger: By tomi, By laparoscopy Incontinence correction: TVT, TOT, other Enteroseel correction 3 Suspension O uterosacral ligament, cardinal ligaments, Apical Suspensions, McCall, Bob Shull, Modified TAIL, Other suspension 1 blood transfusion M Before surgery -------- erythrocyte unit During surgery --------- Red blood cell unit After surgery -------- erythrocyte unit 3 prophylaxis M M M M Preoperative tranexamic acid prophylaxis Antibiotic prophylaxis: Perioperative antibiotics given Prescribing antibiotics during surgery Cefazolin-Cefoxetine-Cefuttan-Cefuroxime-Ampicillin-Sulbactam In penicillin-sensitive patients: Metronidazole + Gentamicin, Metronidazole + Quinolone, Clindamycin + Gentamicin, Clindamycin + quinolone, Clindamycin + Aztero Noam, Metronidazole + Cefazolin, Other Thrombosis prophylaxis: Postoperative Heparin: Rapid and frequent embolization, Mechanical prophylaxis with pneumatic compression intermittent Pharmacological or mechanical prophylaxis Pharmacological and mechanical prophylaxis Unfractionated heparin 5000 Enoxaparin 40 mg, Enoxaparin 40 mg + heparin Pain prophylaxis: NSAID use (mefenamic acid, ibuprofen, naproxen, celecoxib, piroxicam/ acetylsalicylic acid (aspirin) 4
Additional interventions & accompanying treatment
M
M
M
M
Salpingectomy:
By tomi, By laparoscopy, In case of vaginal surgery: Right TUL1/ Left TUL2
Salpingo-oophorectomy:
By tomi or vaginal/ unilat, By tomi or vaginal bilat, By laparoscopy unilat, By laparoscopy bilat
Prolapse surgery:
Front wall plastic, back wall plastic
Colpoperineoplasty
M
M
M
Adherence solution, larger:
By tomi, By laparoscopy
Incontinence correction:
TVT, TOT, other
Enteroseel correction
Before surgery -------- erythrocyte unit
During surgery --------- Red blood cell unit
After surgery -------- erythrocyte unit
M
M
M
M
Preoperative tranexamic acid prophylaxis
Antibiotic prophylaxis:
Perioperative antibiotics given
Prescribing antibiotics during surgery
Cefazolin-Cefoxetine-Cefuttan-Cefuroxime-Ampicillin-Sulbactam
In penicillin-sensitive patients:
Metronidazole + Gentamicin, Metronidazole + Quinolone, Clindamycin + Gentamicin, Clindamycin + quinolone, Clindamycin + Aztero Noam, Metronidazole + Cefazolin, Other
Thrombosis prophylaxis:
Postoperative Heparin: Rapid and frequent embolization, Mechanical prophylaxis with pneumatic compression intermittent
Pharmacological or mechanical prophylaxis
Pharmacological and mechanical prophylaxis
Unfractionated heparin 5000
Enoxaparin 40 mg, Enoxaparin 40 mg + heparin
Pain prophylaxis: NSAID use (mefenamic acid, ibuprofen, naproxen, celecoxib, piroxicam/ acetylsalicylic acid (aspirin)
Table 6 lists complications, including complications during surgery, changes in the surgical method, adverse reactions, findings and reoperation during the same hospitalization.
Table 6 Peroperative complications Main class Subclass Mandatory/ Optional data Data elements The Number of data elements Peroperative complications Serious complication during surgery M M Bladder damage, Ureteral injury, Intestinal damage More than 1000 ml of surgical leakage Vascular damage: Epigastric vessels / Large vessels (Aorta, vena cava, Iliac) / Other vessels/Complications of anesthesia 2 Converted perioperatively M Converted perioperatively: Laparoscopy to laparotomy, Vaginal to laparotomy 1 Complications during hospitalization M M M M M M Complications cause: Infection: Bladder inflammation, wound or slit infection (requires antibiotics, puncture, evacuation), chest infection, pelvic infection (hematoma or abscess) Urinary tract infection (urine culture above 10 5 ) Fever of unknown cause (axillary fever above 38 degrees) Bleeding: bleeding/hematoma of vaginal arch, intraperitoneal bleeding, post-operative bleeding/hematoma Organ damage: Urinary tract damage (ureter, bladder), urogenital fistula, intestinal damage, difficulty in bowel movements, Intestinal obstruction after surgery, prolapse of pelvic organs. Complications of wounds: hernia, abdominal/pelvic abscess, abdominal-pelvic fascia tear, pain, neuropathy Hematoma formation Deep vein thrombosis, Pulmonary embolism Foreign body remains in the abdomen Anemia: (blood transfusion) Other 6
Peroperative complications
M
M
Bladder damage, Ureteral injury, Intestinal damage
More than 1000 ml of surgical leakage
Vascular damage: Epigastric vessels / Large vessels (Aorta, vena cava, Iliac) / Other vessels/Complications of anesthesia
Converted perioperatively:
Laparoscopy to laparotomy, Vaginal to laparotomy
M
M
M
M
M
M
Complications cause:
Infection: Bladder inflammation, wound or slit infection (requires antibiotics, puncture, evacuation), chest infection, pelvic infection (hematoma or abscess)
Urinary tract infection (urine culture above 10 5 )
Fever of unknown cause (axillary fever above 38 degrees)
Bleeding: bleeding/hematoma of vaginal arch, intraperitoneal bleeding, post-operative bleeding/hematoma
Organ damage: Urinary tract damage (ureter, bladder), urogenital fistula, intestinal damage, difficulty in bowel movements, Intestinal obstruction
after surgery, prolapse of pelvic organs.
Complications of wounds: hernia, abdominal/pelvic abscess, abdominal-pelvic fascia tear, pain, neuropathy
Hematoma formation
Deep vein thrombosis, Pulmonary embolism
Foreign body remains in the abdomen
Anemia: (blood transfusion)
Other
Pathology findings and readmission and repeat surgery up to 30 days after patient discharge, were classified in the follow-up data group (Table 7 ).
Table 7 Follow up data Main class Subclass Mandatory/ Optional data Data elements The Number of data elements Pathology Pathological results M Chronic salpingitis, Dysplasia of the cervix, Metaplasia, Leiomyosarcoma, Cancer of cervix, Endometrioid Adenocarcinoma, Serous adenocarcinoma, Clear cell carcinoma, Endometrial hyperplasia without atypia Benign leiomyoma, Metaplasia, Endometrial hyperplasia with atypia, Endometriosis, Endometritis, Neoplastic ovarian cyst, Adenomyosis, Hydrosalpinx, Other 1 Complications Complications and readmission M M M M M M Date of readmission (maximum 30 days after discharge) Cause of hospitalization, Infection: Inflammation of the bladder Wound or cleft infection requires antibiotics Chest infection, Intra-abdominal infection Urinary tract infection (urine culture above 10 5 ) Fever with unknown cause (axillary fever above 38 degrees), Pelvic infection (hematoma or abscess) Hemorrhage: Hemorrhage or wound hematoma Hemorrhage / Hematoma of the vaginal top Intraperitoneal Hemorrhage Injury: Injury of the urinary tract (ureter, bladder), Intestinal injury, Difficulty bowel movements, Postoperative bowel obstruction, Pelvic organ prolapse, urogenital fistula obstruction after hysterectomy, DVT, Anemia: (blood transfusion) Pulmonary embolism, Pain, alone the reason for readmission, Neuropathy 6 Reoperation procedure in Vaginal cuff rupture M M Cause of reoperation: Vaginal cuff dehiscence: Partial superficial defect / Complete wall defect/ Unspecified vaginal obstruction Reoperation procedure: Vaginal cuff rupture repair: Laparotomy Surgery / Laparoscopic surgery /Vaginal surgery 2
Follow up data
M
M
M
M
M
M
Date of readmission (maximum 30 days after discharge)
Cause of hospitalization,
Infection: Inflammation of the bladder
Wound or cleft infection requires antibiotics
Chest infection, Intra-abdominal infection
Urinary tract infection (urine culture above 10 5 ) Fever with unknown cause (axillary fever above 38 degrees), Pelvic infection (hematoma or abscess)
Hemorrhage: Hemorrhage or wound hematoma
Hemorrhage / Hematoma of the vaginal top
Intraperitoneal Hemorrhage
Injury: Injury of the urinary tract (ureter, bladder), Intestinal injury, Difficulty bowel movements, Postoperative bowel obstruction, Pelvic organ prolapse, urogenital fistula
obstruction after hysterectomy, DVT,
Anemia: (blood transfusion)
Pulmonary embolism, Pain, alone the reason for readmission, Neuropathy
Reoperation procedure in
Vaginal cuff rupture
M
M
Cause of reoperation:
Vaginal cuff dehiscence: Partial superficial defect / Complete wall defect/ Unspecified vaginal obstruction
Reoperation procedure:
Vaginal cuff rupture repair: Laparotomy Surgery / Laparoscopic surgery /Vaginal surgery
In the next phase, web-based Hysterectomy registration software was developed with Visual Studio2019 (Fig. 1 ).
Fig. 1 An example of hysterectomy registration system page
An example of hysterectomy registration system page
Automatic calculation of the total number of patients, figures and percentages for each hysterectomy method, an average age as well as a Technicity index in hysterectomies are part of the system dashboard reports. (Fig. 2 ).
Fig. 2 Dashboard of hysterectomy registry system
Dashboard of hysterectomy registry system
There is an important feature in the hysterectomy registration system, which computes and displays a Technicity index at real-time. The Technicity Index (TI) is a quality metric for hysterectomy, calculated by dividing the number of minimally invasive hysterectomies by the total number of hysterectomies performed during a specific period. A higher TI indicates better quality patient care [ 25 , 26 ]. A visual diagram also shows the frequency of hysterectomy indications and pathological findings.
Despite the fact that this registry is designed to be used for prospective purposes, during the two months between 21 March and 22 May 2023 patients who were admitted to AlZahra Referral Hospital in Tabriz have had their data retrospectively recorded on paper forms entered into the system with a view to evaluating the effectiveness of the Registry System and ensuring its accuracy.Data from 40 patients have been included in the study and have been successfully registered in the system, out of a total of 54 identified patients. Table 8 presents the initial findings, which indicate that the vast majority (92.5%) of hysterectomies were performed abdominally, with a small percentage (5%) utilizing the LAVH method and an even smaller percentage (2.5%) being performed vaginally. Additionally, over 70% of patients were between the ages of 45 and 55. The most frequently reported pathological findings in our study were leiomyoma, benign ovarian cysts, and adenomyosis. According to the findings of this study, the technicity index in this period of time 5% was reported (Table 8 ).
Table 8 Initial results from registered patient in system Variables Frequency percent
Patient age:
-<40 years 40–55 years 56–65 1 31 9 2.5 77.5 22.5
Hysterectomy method:
Abdominal (AH) total subtotal radical Vaginal (TVH) LAVH Laparoscopic (TLH) 37 33 1 4 1 2 0 92.5 89 2.7 10.8 2.5 5 0
Initial results from registered patient in system
-<40 years
40–55 years
56–65
1
31
9
2.5
77.5
22.5
Abdominal (AH)
total
subtotal
radical
Vaginal (TVH)
LAVH
Laparoscopic (TLH)
37
33
1
4
1
2
0
92.5
89
2.7
10.8
2.5
5
0